A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of infliximab, the
active ingredient in Remicade, for the treatment of cachexia in pancreatic cancer patients
who are receiving chemotherapy with gemcitabine.